Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marjolein Vermeer"'
Autor:
Esmee Koedoot, Eline van Steijn, Marjolein Vermeer, Román González-Prieto, Alfred C. O. Vertegaal, John W. M. Martens, Sylvia E. Le Dévédec, Bob van de Water
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-17 (2021)
Abstract Background Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited therapeutic opportunities. Recently, splicing factors have gained attention as potential targets for cancer treatment. Here we systematica
Externí odkaz:
https://doaj.org/article/965c99b87fb3412fb4c7057176e1ddb5
Autor:
Bart Kramer, Luuk de Haan, Marjolein Vermeer, Thomas Olivier, Thomas Hankemeier, Paul Vulto, Jos Joore, Henriëtte L. Lanz
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 18, p 4647 (2019)
Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most lethal cancers due to a high chemoresistance and poor vascularization, which results in an ineffective systemic therapy. PDAC is characterized by a high intratumoral pressure, which is not ca
Externí odkaz:
https://doaj.org/article/d79910a9b0ca4e769269a7f4bfdf574d
Autor:
Eline van Steijn, Esmee Koedoot, Marjolein Vermeer, Alfred C.O. Vertegaal, Román González-Prieto, John W.M. Martens, Bob van de Water, Sylvia E. Le Dévédec
Publikováno v:
Journal of Experimental & Clinical Cancer Research, 40. Springer Science and Business Media LLC
Journal of Experimental and Clinical Cancer Research, 40(1). BMC
Journal of Experimental & Clinical Cancer Research, 40(1):82. BioMed Central Ltd.
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-17 (2021)
Journal of Experimental and Clinical Cancer Research, 40(1). BMC
Journal of Experimental & Clinical Cancer Research, 40(1):82. BioMed Central Ltd.
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-17 (2021)
Background Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited therapeutic opportunities. Recently, splicing factors have gained attention as potential targets for cancer treatment. Here we systematically evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::738ae893f8d5ab122e39b6a7d3e78fa3
http://hdl.handle.net/1887/3204454
http://hdl.handle.net/1887/3204454
Autor:
Jos Joore, Henriëtte L. Lanz, Thomas Hankemeier, Paul Vulto, Marjolein Vermeer, Luuk de Haan, Bart Kramer, Thomas Olivier
Publikováno v:
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(18), 4647. MDPI
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
International Journal of Molecular Sciences
Volume 20
Issue 18
International Journal of Molecular Sciences, Vol 20, Iss 18, p 4647 (2019)
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
International Journal of Molecular Sciences
Volume 20
Issue 18
International Journal of Molecular Sciences, Vol 20, Iss 18, p 4647 (2019)
Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most lethal cancers due to a high chemoresistance and poor vascularization, which results in an ineffective systemic therapy. PDAC is characterized by a high intratumoral pressure, which is not ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7134c5193cd1cc419aec546e1ace5e46
http://hdl.handle.net/1887/83622
http://hdl.handle.net/1887/83622
Autor:
Henriëtte L. Lanz, Angelique van den Heuvel, Remi Dulize, Thomas Olivier, Carine Poussin, Marjolein Vermeer, Bart Kramer, Manuel C. Peitsch, Karine Baumer, Emmanuel Guedj, Alexandra Laurent, Nikolai V. Ivanov, Jos Joore, Dariusz Peric, Julia Hoeng
Publikováno v:
ALTEX. 37(1)
Lifestyle and genetic factors can lead to the development of atherosclerosis and, ultimately, cardiovascular adverse events. Rodent models are commonly used to investigate mechanism(s) of atherogenesis. However, the 3Rs principles, aiming to limit an